These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12959325)

  • 1. Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Chimirri A; Monforte P; Rao A; Zappalà M; Monforte AM; De Sarro G; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E
    Antivir Chem Chemother; 2001 May; 12(3):169-74. PubMed ID: 12959325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
    Chimirri A; Grasso S; Monforte P; Rao A; Zappalà M; Monforte AM; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E
    Antivir Chem Chemother; 1999 Jul; 10(4):211-7. PubMed ID: 10480739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Ferro S; De Luca L; Lo Surdo G; Morreale F; Pannecouque C; Balzarini J; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(4):1459-67. PubMed ID: 24457088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
    Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
    Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
    Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
    Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles.
    Rao A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
    Farmaco; 2002 Oct; 57(10):819-23. PubMed ID: 12420877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural optimization of N
    Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S
    Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Monforte AM; Logoteta P; De Luca L; Iraci N; Ferro S; Maga G; De Clercq E; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2010 Feb; 18(4):1702-10. PubMed ID: 20097079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
    Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
    J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
    Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
    J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the research of 2,3-diaryl-1,3-thiazolidin-4-one derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Tian Y; Zhan P; Rai D; Zhang J; De Clercq E; Liu X
    Curr Med Chem; 2012; 19(13):2026-37. PubMed ID: 22429098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
    Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
    J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Khalifa NM; Al-Omar MA
    Int J Mol Sci; 2014 Nov; 15(11):20723-35. PubMed ID: 25397597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
    Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
    J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.
    Kim J; Ok T; Park C; So W; Jo M; Kim Y; Seo M; Lee D; Jo S; Ko Y; Choi I; Park Y; Yoon J; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Liuzzi M; Sommer P; No Z
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2522-6. PubMed ID: 22374216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Xiaohe Z; Yu Q; Hong Y; Xiuqing S; Rugang Z
    Chem Biol Drug Des; 2010 Oct; 76(4):330-9. PubMed ID: 20731670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
    Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.